Norges Bank Axogen, Inc. Transaction History

Norges Bank

$716 Trillion
Q3 2024

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.67 - $8.06 $840,861 - $1.2 Million	148,300 New	148,300 $1.07 Million
Q4 2023 Feb 09, 2024	BUY	$3.61 - $7.76 $818,387 - $1.76 Million	226,700 New	226,700 $1.55 Million
Q3 2023 Nov 13, 2024	BUY	$4.68 - $9.26 $54,451 - $107,740	11,635 New	11,635 $58,000
Q3 2023 Nov 13, 2023	SELL	$4.68 - $9.26 $54,451 - $107,740	-11,635 Closed	0 $0
Q2 2023 Aug 14, 2024	SELL	$8.5 - $10.38 $1.16 Million - $1.42 Million	-136,665 Reduced 92.15%	11,635 $106,000
Q2 2023 Aug 14, 2023	SELL	$8.5 - $10.38 $98,897 - $120,771	-11,635 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$7.53 - $10.95 $87,611 - $127,403	11,635 New	11,635 $109,000
Q4 2022 Feb 14, 2023	BUY	$9.44 - $13.09 $109,834 - $152,302	11,635 New	11,635 $116,000
Q3 2022 Nov 13, 2023	BUY	$8.14 - $12.25 $94,708 - $142,528	11,635 New	11,635 $138,000
Q2 2022 Aug 14, 2023	BUY	$6.99 - $10.0 $81,328 - $116,350	11,635 New	11,635 $95,000
Q1 2022 May 09, 2022	SELL	$7.26 - $10.7 $84,470 - $124,494	-11,635 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$8.8 - $16.0 $102,388 - $186,160	11,635 New	11,635 $109,000
Q3 2021 Nov 14, 2022	BUY	$15.23 - $21.72 $177,201 - $252,712	11,635 New	11,635 $184,000
Q3 2021 Nov 05, 2021	SELL	$15.23 - $21.72 $177,201 - $252,712	-11,635 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$17.8 - $23.5 $207,103 - $273,422	11,635 New	11,635 $251,000
Q2 2021 Aug 10, 2021	SELL	$17.8 - $23.5 $207,103 - $273,422	-11,635 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$17.18 - $22.6 $199,889 - $262,951	11,635 New	11,635 $236,000
Q1 2021 May 07, 2021	SELL	$17.18 - $22.6 $662,752 - $871,840	-38,577 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$11.5 - $17.96 $443,635 - $692,842	38,577 New	38,577 $691,000
Q4 2020 Feb 10, 2021	SELL	$11.5 - $17.96 $443,635 - $692,842	-38,577 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$10.62 - $13.12 $409,687 - $506,130	38,577 New	38,577 $449,000
Q3 2020 Nov 10, 2020	SELL	$10.62 - $13.12 $2.59 Million - $3.19 Million	-243,501 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$7.35 - $10.81 $1.79 Million - $2.63 Million	243,501 New	243,501 $2.25 Million
Q2 2020 Aug 07, 2020	SELL	$7.35 - $10.81 $1.31 Million - $1.93 Million	-178,532 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$8.38 - $17.34 $1.5 Million - $3.1 Million	178,532 New	178,532 $1.86 Million
Q1 2020 May 08, 2020	SELL	$8.38 - $17.34 $1.5 Million - $3.1 Million	-178,532 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$11.18 - $18.6 $2 Million - $3.32 Million	178,532 New	178,532 $3.19 Million
Q4 2019 Feb 12, 2020	SELL	$11.18 - $18.6 $563,371 - $937,272	-50,391 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$12.09 - $20.46 $609,227 - $1.03 Million	50,391 New	50,391 $629,000
Q3 2019 Nov 08, 2019	SELL	$12.09 - $20.46 $609,227 - $1.03 Million	-50,391 Closed	0 $0
Q2 2019 Aug 13, 2020	BUY	$18.5 - $25.47 $932,233 - $1.28 Million	50,391 New	50,391 $998,000
Q2 2019 Aug 09, 2019	SELL	$18.5 - $25.47 $932,233 - $1.28 Million	-50,391 Closed	0 $0
Q4 2018 Mar 04, 2019	BUY	$17.09 - $38.25 $861,182 - $1.93 Million	50,391 New	50,391 $1.03 Million
Q4 2018 Feb 08, 2019	SELL	$17.09 - $38.25 $861,182 - $1.93 Million	-50,391 Closed	0 $0
Q3 2018 Nov 12, 2019	BUY	$34.05 - $55.9 $1.72 Million - $2.82 Million	50,391 New	50,391 $1.86 Million

Others Institutions Holding AXGN

# of Institutions

162

Shares Held

36.6M

Call Options Held

230K

Put Options Held

400

First Light Asset Management, LLC Edina, MN

4.09M
Shares

$64 Million
5.0% of portfolio
Black Rock Inc. New York, NY

3.25M
Shares

$50.8 Million
0.0% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

3.01M
Shares

$47 Million
3.58% of portfolio
Morgan Stanley New York, NY

2.9M
Shares

$45.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.43M
Shares

$37.9 Million
0.0% of portfolio

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $661M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account